112 related articles for article (PubMed ID: 7937680)
1. The cardiovascular effects of adenosine: clinical use and nursing implications.
Teplitz L
Prog Cardiovasc Nurs; 1993; 8(2):20-8. PubMed ID: 7937680
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular drugs: adenosine role in coronary syndromes and percutaneous coronary interventions.
Rosales OR; Eades B; Assali AR
Catheter Cardiovasc Interv; 2004 Jul; 62(3):358-63. PubMed ID: 15224305
[TBL] [Abstract][Full Text] [Related]
3. [Adenosine as an anti-arrhythmia agent].
Hellwig B
Med Monatsschr Pharm; 1995 May; 18(5):114-6. PubMed ID: 7791668
[No Abstract] [Full Text] [Related]
4. Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins.
Zhao ZQ; Budde JM; Morris C; Wang NP; Velez DA; Muraki S; Guyton RA; Vinten-Johansen J
J Mol Cell Cardiol; 2001 Jan; 33(1):57-68. PubMed ID: 11133223
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
6. The pharmacology of adenosine.
Pelleg A; Porter RS
Pharmacotherapy; 1990; 10(3):157-74. PubMed ID: 2196534
[TBL] [Abstract][Full Text] [Related]
7. Adenosine in the heart: its emerging roles.
Pelleg A
Hosp Pract (Off Ed); 1993 Mar; 28(3):71-4, 78, 81-3, passim. PubMed ID: 8383138
[TBL] [Abstract][Full Text] [Related]
8. [The comparative characteristics and receptor mechanism of the effect of adenosine-receptor agonists in total cerebral ischemia].
Kulinskiĭ VI; Usov LA; Sufianova GZ; Lidak MIu; Iurkevich AM
Eksp Klin Farmakol; 1993; 56(6):13-6. PubMed ID: 8111286
[TBL] [Abstract][Full Text] [Related]
9. Targeting adenosine receptors in the development of cardiovascular therapeutics.
Riksen NP; Rongen GA
Expert Rev Clin Pharmacol; 2012 Mar; 5(2):199-218. PubMed ID: 22390562
[TBL] [Abstract][Full Text] [Related]
10. Adenosine in the pediatric population: nursing implications.
Zeigler V
Pediatr Nurs; 1991; 17(6):600-2. PubMed ID: 1754289
[TBL] [Abstract][Full Text] [Related]
11. Role of adenosine as adjunctive therapy in acute myocardial infarction.
Forman MB; Stone GW; Jackson EK
Cardiovasc Drug Rev; 2006; 24(2):116-47. PubMed ID: 16961725
[TBL] [Abstract][Full Text] [Related]
12. Clinical management of supraventricular tachycardia with adenosine.
Chronister C
Am J Crit Care; 1993 Jan; 2(1):41-7. PubMed ID: 8353577
[TBL] [Abstract][Full Text] [Related]
13. The anti-infarct effect of an adenosine A1-selective agonist is diminished after prolonged infusion as is the cardioprotective effect of ischaemic preconditioning in rabbit heart.
Tsuchida A; Thompson R; Olsson RA; Downey JM
J Mol Cell Cardiol; 1994 Mar; 26(3):303-11. PubMed ID: 8028014
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of action and therapeutic potential of adenosine and its analogues in the treatment of cardiac arrhythmias.
Pelleg A
Coron Artery Dis; 1993 Jan; 4(1):109-15. PubMed ID: 7505714
[TBL] [Abstract][Full Text] [Related]
15. Adenosine and neuroprotection.
Fredholm BB
Int Rev Neurobiol; 1997; 40():259-80. PubMed ID: 8989624
[TBL] [Abstract][Full Text] [Related]
16. Experimental off-pump coronary artery revascularization with adenosine-enhanced reperfusion.
Muraki S; Morris CD; Budde JM; Velez DA; Zhao ZQ; Guyton RA; Vinten-Johansen J
J Thorac Cardiovasc Surg; 2001 Mar; 121(3):570-9. PubMed ID: 11241093
[TBL] [Abstract][Full Text] [Related]
17. Adenosine-induced chest pain: is it due to myocardial ischaemia? Clinical, electrocardiographic, haemodynamic and metabolic study.
Mehta AB; Mardikar HM; Hiregoudar NS; Sethi RB; Solanki DR; Mathew R
Indian Heart J; 1997; 49(3):267-70. PubMed ID: 9291647
[TBL] [Abstract][Full Text] [Related]
18. [The biophysiology of the cardiovascular system and its therapeutic implications].
Michel D
Internist (Berl); 1984 Aug; 25(8):478-84. PubMed ID: 6384113
[No Abstract] [Full Text] [Related]
19. Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence.
Jordan JE; Zhao ZQ; Sato H; Taft S; Vinten-Johansen J
J Pharmacol Exp Ther; 1997 Jan; 280(1):301-9. PubMed ID: 8996210
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
Nekooeian AA; Tabrizchi R
Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
